Market Overview:
The global herpes labialis treatment market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The market growth is attributed to the increasing prevalence of herpes labialis, rising awareness about the available treatments, and growing demand for better-tolerated therapies. Based on type, the global herpes labialis treatment market is segmented into acyclovir, valacyclovir, famciclovir, penciclovir, and docosanol. Acyclovir dominates the market due to its high efficacy and safety profile. However, valacyclovir is expected to grow at a higher CAGR during the forecast period owing to its better tolerability profile as compared with acyclovir. Based on application, the global herpes labialis treatment market is segmented into topical and oral applications. Topical applications are further sub-segmented into ointments/creams/gels and patches/sticks/sprays. Oral applications are further sub-segmented into tablets/capsules and syrups/liquids/.
Product Definition:
Herpes labialis treatment is the use of medication to treat an outbreak of herpes simplex virus on the lips. The purpose of herpes labialis treatment is to reduce the symptoms and duration of an outbreak.
Acyclovir:
Acyclovir is a medication used for the treatment of recurrent genital herpes. It’s mechanism of action is by inhibiting viral DNA polymerase. This drug has been found to be effective in the treatment of patients suffering from both first and second degree Herpes labialis infections. The drug has also been found to significantly reduce pain, itching, and discharge associated with Herpes labialis infection thus improving patient compliance rates during therapy.
Valacyclovir:
Valacyclovir is an antiviral medication used for the treatment of recurrent labial herpes. It is also used to prevent future outbreaks by about 60% to 70%. Valacyclovir hydrochloride tablets are approved by the U.S. FDA and EMA for the treatment of recurrent labial herpes simplex virus (HSV) infection in adults and children above five years of age, respectively.
Application Insights:
Based on the application, the global market is segmented into topical, oral and others. The topical application segment dominated the overall industry in terms of revenue in 2017. This can be attributed to increasing awareness about genital herpetic disease and growing prevalence of HSV infection. As per WHO, around 60% to 90% of people are infected with HSV at some point during their life span. Around 20 million people are estimated to be suffering from HSV worldwide which is expected to boost demand for treatment across various regions over the forecast period.
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of manufacturers and suppliers, high awareness levels coupled with the availability of highly effective drugs are some factors attributing to its largest share. Moreover, increasing prevalence rates for genital herpes is also expected to drive regional growth over the forecast period.
Asia Pacific is estimated to be fastest-growing region during the forecast period owing to growing demand for cost-effective drugs and rising patient awareness levels about available treatment options. Valacyclovir, acyclovir and famciclovir are available at low prices in this region as a result of extensive marketing by local drug manufacturers such as Gilead Sciences India Ltd., Sun Pharmaceutical Industries Ltd., Cipla Inc., Merck KGaA Dohle AG & Co.
Growth Factors:
- Increasing incidence of herpes labialis
- Growing awareness about the treatment options for herpes labialis
- Rising demand for home-based remedies for herpes labialis treatment
- Availability of a wide range of effective over-the-counter medications for herpes labialis treatment
- increasing research and development activities focused on the development of new and improved therapies for herpes labialis
Scope Of The Report
Report Attributes
Report Details
Report Title
Herpes Labialis Treatment Market Research Report
By Type
Acyclovir, Valacyclovir, Famciclovir, Penciclovir, Docosanol
By Application
Topical, Oral
By Companies
Teva, Abbott, Sun, Mylan, Pfizer, GlaxoSmithKline, Dr. Reddy's, Novartis
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
164
Number of Tables & Figures
115
Customization Available
Yes, the report can be customized as per your need.
Global Herpes Labialis Treatment Market Report Segments:
The global Herpes Labialis Treatment market is segmented on the basis of:
Types
Acyclovir, Valacyclovir, Famciclovir, Penciclovir, Docosanol
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Topical, Oral
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Teva
- Abbott
- Sun
- Mylan
- Pfizer
- GlaxoSmithKline
- Dr. Reddy's
- Novartis
Highlights of The Herpes Labialis Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Acyclovir
- Valacyclovir
- Famciclovir
- Penciclovir
- Docosanol
- By Application:
- Topical
- Oral
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Herpes Labialis Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
There is no one-size-fits-all answer to this question, as the best herpes labialis treatment will vary depending on the individual's symptoms and medical history. However, some possible treatments include antiviral medication or topical creams.
Some of the major players in the herpes labialis treatment market are Teva, Abbott, Sun, Mylan, Pfizer, GlaxoSmithKline, Dr. Reddy's, Novartis.
The herpes labialis treatment market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Herpes Labialis Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Herpes Labialis Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Herpes Labialis Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Herpes Labialis Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Herpes Labialis Treatment Market Size & Forecast, 2020-2028
4.5.1 Herpes Labialis Treatment Market Size and Y-o-Y Growth
4.5.2 Herpes Labialis Treatment Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Acyclovir
5.2.2 Valacyclovir
5.2.3 Famciclovir
5.2.4 Penciclovir
5.2.5 Docosanol
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Topical
6.2.2 Oral
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Herpes Labialis Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Herpes Labialis Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Acyclovir
9.6.2 Valacyclovir
9.6.3 Famciclovir
9.6.4 Penciclovir
9.6.5 Docosanol
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Topical
9.10.2 Oral
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Acyclovir
10.6.2 Valacyclovir
10.6.3 Famciclovir
10.6.4 Penciclovir
10.6.5 Docosanol
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Topical
10.10.2 Oral
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Acyclovir
11.6.2 Valacyclovir
11.6.3 Famciclovir
11.6.4 Penciclovir
11.6.5 Docosanol
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Topical
11.10.2 Oral
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Acyclovir
12.6.2 Valacyclovir
12.6.3 Famciclovir
12.6.4 Penciclovir
12.6.5 Docosanol
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Topical
12.10.2 Oral
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Acyclovir
13.6.2 Valacyclovir
13.6.3 Famciclovir
13.6.4 Penciclovir
13.6.5 Docosanol
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Topical
13.10.2 Oral
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Herpes Labialis Treatment Market: Competitive Dashboard
14.2 Global Herpes Labialis Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Teva
14.3.2 Abbott
14.3.3 Sun
14.3.4 Mylan
14.3.5 Pfizer
14.3.6 GlaxoSmithKline
14.3.7 Dr. Reddy's
14.3.8 Novartis
